BTFC Awards $3 Million to Four Primary Brain Tumor Immunotherapy Research Projects

Recently, VCBeat (WeChat official account: vcbeat) learned that the Brain Tumor Funders’ Collaborative (hereinafter referred to as BTFC) announced it would provide $3 million in funding to four brain tumor research projects from different institutions to study methods of immunotherapy for primary brain tumors.

This investment is conducted in partnership with multiple U.S. charitable organizations, namely: the American Brain Tumor Association (hereinafter referred to as ABTA), the Brain Tumor Foundation of Canada, the James S. McDonnell Foundation, the Pediatric Brain Tumor Foundation, and the Santagata Foundation.

BTFC was jointly established by the five aforementioned private foundations and other non-profit organizations, with the aim of pooling top-tier technical resources and financial support to make brain tumor research projects more targeted and efficient. In addition to basic research investment, BTFC also allocates funds to promote public awareness of brain tumor-related issues.

Previously, BTFC issued a request for comments to the public. Among the 79 responses received, BTFC conducted multiple rounds of review and ultimately selected four research projects for investment: the “Vaccination Strategies” project at the David Geffen School of Medicine at UCLA; the “Leveraging the Immune Microenvironment of Brain Tumors to Enhance Therapeutic Efficacy” project at McGill University; the “Anti-Tumor T-Cell Research” project at UPMC Children’s Hospital of Pittsburgh; and the “Personalized Immunotherapy Approaches” project at the University of California, San Francisco. Each of these institutions will receive a grant of $750,000 over the next three years.

Ralph DeVitto, President and CEO of the American Brain Tumor Association (ABTA), stated, “It is an exceptionally rare and valuable opportunity to collaborate with so many like-minded organizations, and we will spare no effort to provide greater financial support for brain tumor research.”

The American Brain Tumor Association is the oldest nonprofit organization in the United States and the first national organization dedicated to funding brain tumor research and providing support and education to patients of all ages. Since its establishment in 1973, the organization has provided more than $30 million in research grants to scientists worldwide.

Brain Tumor Foundation of Canada, established in 1982 and headquartered in Canada, derives its funding primarily from donations by individuals, corporations, and employee groups.

The James S. McDonnell Foundation was established in 1950. Since its inception, the foundation has awarded more than $450 million in grants to the fields of science, education, and philanthropy.

The Pediatric Brain Tumor Foundation is dedicated to raising funds for pediatric brain tumor research and supporting families in financial hardship. Meanwhile, the organization continuously conducts nationwide engaging science popularization activities to raise public awareness of pediatric brain tumors.

Since its establishment in 2002, the Pediatric Brain Tumor Foundation has awarded $33 million to support brain cancer research. In addition, the foundation has established an annual Distinguished Scientist Award to encourage scientists who have made significant advances in the field.